Cargando…

Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo

Background: There is anecdotal evidence that ivermectin may decrease seizure frequency in Onchocerca volvulus-infected persons with epilepsy (PWE). Methods: In October 2017, a 12-month clinical trial was initiated in rural Democratic Republic of Congo. PWE with onchocerciasis-associated epilepsy exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mandro, Michel, Siewe Fodjo, Joseph Nelson, Dusabimana, Alfred, Mukendi, Deby, Haesendonckx, Steven, Lokonda, Richard, Nakato, Swabra, Nyisi, Francoise, Abhafule, Germain, Wonya’rossi, D, Hotterbeekx, An, Abrams, Steven, Colebunders, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157533/ https://www.ncbi.nlm.nih.gov/pubmed/32164367 http://dx.doi.org/10.3390/pathogens9030205

Ejemplares similares

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial
por: Mandro, Michel, et al.
Publicado: (2020)

Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Urinary N-acetyltyramine-O,β-glucuronide in Persons with Onchocerciasis-Associated Epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2020)

Serotonin Levels in the Serum of Persons with Onchocerciasis-Associated Epilepsy: A Case-Control Study
por: Vieri, Melissa Krizia, et al.
Publicado: (2021)

High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo
por: Lenaerts, Evy, et al.
Publicado: (2018)

Comparison of Diagnostic Tests for Onchocerca volvulus in the Democratic Republic of Congo
por: Hotterbeekx, An, et al.
Publicado: (2020)

Economic Burden of Epilepsy in Rural Ituri, Democratic Republic of Congo
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo
por: Dolo, Housseini, et al.
Publicado: (2018)

High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment
por: Mukendi, Deby, et al.
Publicado: (2019)

Ivermectin Treatment in Patients With Onchocerciasis-Associated Epilepsy: Protocol of a Randomized Clinical Trial
por: Colebunders, Robert, et al.
Publicado: (2017)

Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study
por: Dusabimana, Alfred, et al.
Publicado: (2020)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Potential Parasitic Causes of Epilepsy in an Onchocerciasis Endemic Area in the Ituri Province, Democratic Republic of Congo
por: Vieri, Melissa Krizia, et al.
Publicado: (2021)

Community perceptions and attitudes regarding epilepsy and disease cost after implementation of a community-based epilepsy treatment program in onchocerciasis-endemic communities in the Democratic Republic of Congo
por: Dusabimana, Alfred, et al.
Publicado: (2021)

OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study
por: Dusabimana, Alfred, et al.
Publicado: (2020)

Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with Onchocerca volvulus
por: Dusabimana, Alfred, et al.
Publicado: (2020)

Ivermectin treatment response in two rural villages with a high prevalence of onchocerciasis and epilepsy, Mahenge Tanzania
por: Bhwana, Dan, et al.
Publicado: (2022)

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening
por: Dusabimana, Alfred, et al.
Publicado: (2022)

Onchocerciasis Prevalence among Persons with Epilepsy in an Onchocerciasis Hypo-Endemic Area in the Democratic Republic of Congo: A Cross-Sectional Study
por: Hotterbeekx, An, et al.
Publicado: (2021)

Low ivermectin use among 5- to 6-year-old children: observations from door-to-door surveys in onchocerciasis-endemic regions in Africa
por: Siewe Fodjo, J N, et al.
Publicado: (2019)

Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281
por: Dusabimana, Alfred, et al.
Publicado: (2022)

The onchocerciasis hypothesis of nodding syndrome
por: Colebunders, Robert, et al.
Publicado: (2023)

Cytokines and Onchocerciasis-Associated Epilepsy, a Pilot Study and Review of the Literature
por: Vieri, Melissa Krizia, et al.
Publicado: (2021)

No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2021)

From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes
por: Colebunders, Robert, et al.
Publicado: (2019)

Onchocerciasis‐associated epilepsy: From recent epidemiological and clinical findings to policy implications
por: Colebunders, Robert, et al.
Publicado: (2017)

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
por: Gumisiriza, Nolbert, et al.
Publicado: (2020)

Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
por: Colebunders, Robert, et al.
Publicado: (2022)

Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy
por: Hotterbeekx, An, et al.
Publicado: (2020)

Impact of a bi-annual community-directed treatment with ivermectin programme on the incidence of epilepsy in an onchocerciasis-endemic area of Mahenge, Tanzania: A population-based prospective study
por: Bhwana, Dan, et al.
Publicado: (2023)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
por: Colebunders, Robert, et al.
Publicado: (2019)

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
por: Boullé, Charlotte, et al.
Publicado: (2019)

Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study
por: Mandro, Michel, et al.
Publicado: (2018)

Meta-analysis of epilepsy prevalence in West Africa and its relationship with onchocerciasis endemicity and control
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2020)

Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
por: Otabil, Kenneth Bentum, et al.
Publicado: (2023)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2018)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
por: Otabil, Kenneth Bentum, et al.
Publicado: (2023)

Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
por: O’Neill, Sarah, et al.
Publicado: (2019)

Assessing Onchocerca volvulus Intensity of Infection and Genetic Diversity Using Mitochondrial Genome Sequencing of Single Microfilariae Obtained before and after Ivermectin Treatment
por: Hedtke, Shannon M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3mjj05cucshb5rm5mv9odhaha4